Basilea Pharmaceutica AG (BSLN) — Cash Flow Reinvestment Rate
Basilea Pharmaceutica AG (BSLN) has a Cash Flow Reinvestment Rate of 0.06x as of December 2025, reinvesting CHF2.30 Million (capex CHF2.30 Million ) from operating cash flow of CHF39.03 Million. See Basilea Pharmaceutica AG (BSLN) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Basilea Pharmaceutica AG Cash Flow Reinvestment Rate (2005–2025)
Historical reinvestment intensity for Basilea Pharmaceutica AG across 8 annual periods. For the full cash flow conversion analysis, see BSLN operating cash flow.
Annual Cash Flow Reinvestment Rate for Basilea Pharmaceutica AG (2005–2025)
Year-by-year capital reinvestment analysis for Basilea Pharmaceutica AG. See Basilea Pharmaceutica AG (BSLN) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CHF) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.04x | CHF2.62 Million | CHF62.09 Million | CHF2.62 Million | ▲ +15.3% |
| 2024 | 0.04x | CHF2.72 Million | CHF74.36 Million | CHF1.71 Million | ▼ -74.8% |
| 2023 | 0.15x | CHF2.07 Million | CHF14.24 Million | CHF1.03 Million | ▼ -98.9% |
| 2022 | 13.46x | CHF94.95 Million | CHF7.06 Million | CHF3.30 Million | ▲ +321.5% |
| 2017 | 3.19x | CHF60.71 Million | CHF19.01 Million | CHF711.00K | ▲ +35705.9% |
| 2012 | 0.01x | CHF1.32 Million | CHF148.17 Million | CHF1.32 Million | ▼ -23.3% |
| 2010 | 0.01x | CHF1.24 Million | CHF106.64 Million | CHF1.24 Million | ▼ -66.7% |
| 2005 | 0.03x | CHF1.20 Million | CHF34.38 Million | CHF1.20 Million | — |